The US FDA said it revoked the emergency use authorization of the Janssen Covid-19 vaccine after the company requested the voluntary withdrawal of the EUA.
- Janssen informed the FDA that the last lots of the vaccine purchased by the US have expired
- No demand for new lots of the vaccine in the US
- No intention to update the strain composition of vaccine to address emerging variants
To view the source of this information, click <-bsp-bb-link state="{"bbDocId":"RVN5LSMB2SJP","_id":"00000188-7dbe-d4e2-a1cb-7fbe44f00000","_type":"0000016b-944a-dc2b-ab6b-d57ba1cc0000"}">here-bsp-bb-link>
To contact the reporter on this story:
<-bsp-person state="{"_id":"00000188-7dbe-d4e2-a1cb-7fbe44f30000","_type":"00000160-6f41-dae1-adf0-6ff519590003"}">Greg Chang-bsp-person> in San Francisco at gchang1@bloomberg.net
To contact the editor responsible for this story:
<-bsp-person state="{"_id":"00000188-7dbe-d4e2-a1cb-7fbe44f50000","_type":"00000160-6f41-dae1-adf0-6ff519590003"}">Chakradhar Adusumilli-bsp-person> at ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.